January 2024 in “CRC Press eBooks” Exopolysaccharides are safer and beneficial alternatives to harmful chemicals in cosmetics.
January 2024 in “La Ciencia al Servicio de la Salud y Nutrición” Spironolactone is effective and safe for treating hair loss, excessive hair growth, and acne.
January 2024 in “Dermatologic therapy” Tofacitinib is a safe treatment for hair loss in children, but long-term use may be needed for best results.
January 2024 in “Journal of Cutaneous and Aesthetic Surgery” The modified needle is safer for procedures by reducing injury risk.
January 2024 in “Wiadomości Lekarskie” Pulmonary artery thrombectomy is safe and effective but not widely used.
January 2024 in “International Journal of Dermatology Venereology and Leprosy Sciences” Tofacitinib may be safe and effective for treating certain skin conditions in children.
December 2023 in “International Journal of Advanced Research in Science, Communication and Technology” Herbal shampoo is safe, effective, and good for hair and scalp health.
December 2023 in “European Journal of Medicinal Chemistry” Natural products might be safe, effective, and affordable treatments for hair loss.
December 2023 in “International Journal of Science and Research (IJSR)” FUE is a safe and effective method for beard and moustache transplants.
November 2023 in “Bioengineering” AMT® is effective and safe for early-stage knee osteoarthritis.
November 2023 in “PubMed” Pentoxifylline is a safe and effective alternative to triamcinolone acetonide for treating localized alopecia areata.
October 2023 in “Peer review” PRP is a safe and effective treatment for hair loss.
Cetosomal minoxidil is safer and as effective as alcohol-based minoxidil for male hair loss treatment.
September 2023 in “Facial Plastic Surgery” FUE is a safe, popular hair transplant method focusing on careful planning and technique.
September 2023 in “Acta dermato-venereologica” Tofacitinib is a safe and effective treatment for hair loss in children with Alopecia Areata.
September 2023 in “PubMed” Baricitinib is a relatively safe and effective treatment for severe alopecia areata.
September 2023 in “Journal of The American Academy of Dermatology” Dutasteride is safe and effective long-term for male hair loss.
September 2023 in “Al-Azhar International Medical Journal /Al-Azhar International Medical Journal” Laparoscopic sleeve gastrectomy is safe and effective for treating obesity in children and teens.
September 2023 in “Journal of the American Academy of Dermatology” Ixekizumab is safe for long-term use with low rates of major heart-related events.
August 2023 in “International journal of research in medical sciences” The serum is safe and helps treat premature greying of hair.
August 2023 in “Chinese Journal of Dermatology” Microneedling is a safe and effective low-cost treatment for hair loss that works better and faster than traditional methods.
June 2023 in “RECIMA21 - Revista Científica Multidisciplinar - ISSN 2675-6218” Phototherapy is a safe and effective treatment for hair loss, but choosing the right power level is important.
June 2023 in “British Journal of Dermatology” Baricitinib was effective and safe for severe hair loss treatment over 6 months.
May 2023 in “Elsevier eBooks” Scalp micropigmentation is a safe way to hide hair loss and scalp scars by tattooing tiny dots that look like hair follicles.
April 2023 in “Research Society and Development” Corticosteroids are safe and effective for treating Alopecia Areata.
April 2023 in “Plastic Surgery” Fat grafting is safe and effective in both active and stable phases of localized scleroderma.
February 2023 in “International Journal of Medical Arts” Trichloroacetic acid is a safe and effective treatment for hair loss in alopecia areata patients.
Follicular unit extraction is safe and effective without bupivacaine and nerve blocks when using lignocaine with adrenaline.
November 2022 in “Journal of Investigative Dermatology” KX-826 is safe and effectively increases hair count in men with hair loss.
The hair masks are safe, stable, and effective for hair care.